Assessment of pulmonary surfactant in COVID-19 patients
Peter Schousboe, Lothar Wiese, Christian Heiring, Henrik Verder, Porntiva Poorisrisak, Povl Verder, Henning B. Nielsen
Abstract
The clinical presentation of coronavirus 2 (SARS-CoV-2) ranges from asymptomatic to severe respiratory failure, and correspondingly requirement for respiratory support ranging from varying levels of supplementary O 2 , to non-invasive and invasive ventilation. In a recent editorial by Gattinoni et al. Furthermore, non-ARDS type COVID-19 pneumonia may transit to ARDS-type COVID-19 by self-inflicted or ventilator-induced lung injury.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pulmonary surfactantIntensive care medicineBetacoronavirusPneumoniaPandemicEmergency medicineInternal medicineVirologyDiseaseInfectious disease (medical specialty)OutbreakPhysicsThermodynamicsRespiratory Support and MechanismsNeonatal Respiratory Health ResearchNeuroscience of respiration and sleep